For Healthcare Professionals: Clinical Updates in Bladder Cancer

Our team of specialists in urology, medical oncology, urologic surgery, radiation oncology, pathology, and radiology diagnose and treat nearly 400 patients with bladder cancer annually.  In addition to expertise in minimally invasive surgery for noninvasive bladder cancer and post-operative Calmette-Guérin (BCG) therapy for patients at high risk of recurrence, our urologic surgeons have extensive experience in cystectomy for invasive bladder cancer; we perform approximately 250 radical cystectomy operations each year. We also offer a range of bladder preservation and reconstructive options and are working to develop new techniques to further improve radiation therapy via intensity-modulated radiation therapy (IMRT) and image-guided radiotherapy (IGRT). Our first-line treatment for metastatic bladder cancer includes standard chemotherapy regimens as well as access to novel drug regimens through clinical trial enrollment.

Leading Edge Options for the Treatment of Bladder Cancer

Bernard Bochner discusses approaches to bladder cancer treatment.

Runtime: 6:00 minutes Published: 07/01/2011 - 12:00 AM
Clinical Trials in Neoadjuvant Therapy for Bladder Cancer

Medical oncologist Dean Bajorin describes novel chemotherapy drugs in development at Memorial Sloan-Kettering that may be given before bladder cancer surgery.

Runtime: 5:00 minutes Published: 02/01/2011 - 12:00 AM
Treatment Strategies for Muscle Invasive Bladder Cancer

Medical oncologist Dean Bajorin talks about combining chemotherapy or radiation with surgery to treat patients with advanced bladder cancer.

Runtime: 2:00 minutes Published: 02/01/2011 - 12:00 AM